Consolidated Statements of Stockholders' Deficit (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023		Dec. 25, 2022		Dec. 26, 2021		Dec. 27, 2020
Net income (loss) allocated to the redeemable noncontrolling interest from joint venture arrangements	$ 198		$ 574		$ 2,609
Stockholders' deficit	443,616		270,664		172,458		$ 266,939
Transaction costs on share repurchases	2,804
Accumulated other comprehensive loss
Stockholders' deficit	7,803	[1]	10,135	[1],[2]	9,971	[2],[3]	$ 14,168	[3]
Net unrealized foreign currency translation loss
Stockholders' deficit	7,490		8,696		4,869
Net unrealized loss on interest rate swap agreements
Stockholders' deficit	314		1,439		5,102
Corporate joint venture
Net income (loss) allocated to the redeemable noncontrolling interest from joint venture arrangements	$ 198		$ 574		$ 2,609

[1] At December 31, 2023, the accumulated other comprehensive loss of $7,803 was comprised of net unrealized foreign currency translation loss of $7,490 and a net unrealized loss on the interest rate swap agreements of $314.

[2] At December 25, 2022, the accumulated other comprehensive loss of $10,135 was comprised of net unrealized foreign currency translation loss of $8,696 and a net unrealized loss on the interest rate swap agreements of $1,439.

[3] At December 26, 2021, the accumulated other comprehensive loss of $9,971 was comprised of net unrealized foreign currency translation loss of $4,869 and a net unrealized loss on the interest rate swap agreements of $5,102.